![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SSBP1 |
Gene summary for SSBP1 |
![]() |
Gene information | Species | Human | Gene symbol | SSBP1 | Gene ID | 6742 |
Gene name | single stranded DNA binding protein 1 | |
Gene Alias | Mt-SSB | |
Cytomap | 7q34 | |
Gene Type | protein-coding | GO ID | GO:0006260 | UniProtAcc | A4D1U3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6742 | SSBP1 | GSM4909282 | Human | Breast | IDC | 3.60e-06 | 3.12e-01 | -0.0288 |
6742 | SSBP1 | GSM4909285 | Human | Breast | IDC | 1.06e-12 | 4.38e-01 | 0.21 |
6742 | SSBP1 | GSM4909286 | Human | Breast | IDC | 5.61e-07 | 1.52e-01 | 0.1081 |
6742 | SSBP1 | GSM4909288 | Human | Breast | IDC | 6.60e-07 | 4.55e-01 | 0.0988 |
6742 | SSBP1 | GSM4909293 | Human | Breast | IDC | 1.59e-04 | 2.35e-01 | 0.1581 |
6742 | SSBP1 | GSM4909294 | Human | Breast | IDC | 9.99e-10 | 3.09e-01 | 0.2022 |
6742 | SSBP1 | GSM4909296 | Human | Breast | IDC | 9.44e-08 | 2.41e-02 | 0.1524 |
6742 | SSBP1 | GSM4909297 | Human | Breast | IDC | 4.37e-14 | -2.48e-01 | 0.1517 |
6742 | SSBP1 | GSM4909308 | Human | Breast | IDC | 2.28e-02 | 2.44e-01 | 0.158 |
6742 | SSBP1 | GSM4909311 | Human | Breast | IDC | 1.25e-34 | -3.84e-01 | 0.1534 |
6742 | SSBP1 | GSM4909312 | Human | Breast | IDC | 1.32e-11 | -2.54e-01 | 0.1552 |
6742 | SSBP1 | GSM4909313 | Human | Breast | IDC | 5.70e-05 | -2.79e-01 | 0.0391 |
6742 | SSBP1 | GSM4909315 | Human | Breast | IDC | 2.07e-41 | 7.85e-01 | 0.21 |
6742 | SSBP1 | GSM4909316 | Human | Breast | IDC | 5.35e-22 | 7.28e-01 | 0.21 |
6742 | SSBP1 | GSM4909317 | Human | Breast | IDC | 3.19e-06 | 3.37e-01 | 0.1355 |
6742 | SSBP1 | GSM4909319 | Human | Breast | IDC | 1.89e-39 | -3.93e-01 | 0.1563 |
6742 | SSBP1 | GSM4909320 | Human | Breast | IDC | 1.50e-04 | -2.30e-01 | 0.1575 |
6742 | SSBP1 | GSM4909321 | Human | Breast | IDC | 1.08e-14 | -2.21e-01 | 0.1559 |
6742 | SSBP1 | brca1 | Human | Breast | Precancer | 6.03e-39 | 7.22e-01 | -0.0338 |
6742 | SSBP1 | brca2 | Human | Breast | Precancer | 7.74e-15 | 4.55e-01 | -0.024 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003304414 | Prostate | Tumor | regulation of chromosome organization | 57/3246 | 187/18723 | 6.74e-06 | 1.02e-04 | 57 |
GO:003239212 | Prostate | Tumor | DNA geometric change | 27/3246 | 90/18723 | 2.15e-03 | 1.22e-02 | 27 |
GO:003250811 | Prostate | Tumor | DNA duplex unwinding | 25/3246 | 84/18723 | 3.47e-03 | 1.79e-02 | 25 |
GO:003304417 | Skin | cSCC | regulation of chromosome organization | 100/4864 | 187/18723 | 8.97e-16 | 7.70e-14 | 100 |
GO:2001252110 | Skin | cSCC | positive regulation of chromosome organization | 45/4864 | 82/18723 | 2.47e-08 | 6.89e-07 | 45 |
GO:000626012 | Skin | cSCC | DNA replication | 106/4864 | 260/18723 | 1.18e-07 | 2.77e-06 | 106 |
GO:003239215 | Skin | cSCC | DNA geometric change | 44/4864 | 90/18723 | 2.53e-06 | 4.06e-05 | 44 |
GO:003250814 | Skin | cSCC | DNA duplex unwinding | 40/4864 | 84/18723 | 1.58e-05 | 1.94e-04 | 40 |
GO:00062755 | Skin | cSCC | regulation of DNA replication | 44/4864 | 107/18723 | 4.41e-04 | 3.39e-03 | 44 |
GO:00705849 | Skin | cSCC | mitochondrion morphogenesis | 13/4864 | 21/18723 | 5.53e-04 | 4.05e-03 | 13 |
GO:00512624 | Skin | cSCC | protein tetramerization | 35/4864 | 87/18723 | 2.52e-03 | 1.43e-02 | 35 |
GO:00711031 | Skin | cSCC | DNA conformation change | 96/4864 | 290/18723 | 3.87e-03 | 2.07e-02 | 96 |
GO:004574011 | Skin | cSCC | positive regulation of DNA replication | 18/4864 | 40/18723 | 7.10e-03 | 3.40e-02 | 18 |
GO:200125223 | Thyroid | HT | positive regulation of chromosome organization | 13/1272 | 82/18723 | 3.41e-03 | 2.64e-02 | 13 |
GO:003304418 | Thyroid | HT | regulation of chromosome organization | 22/1272 | 187/18723 | 8.36e-03 | 4.79e-02 | 22 |
GO:003304419 | Thyroid | PTC | regulation of chromosome organization | 102/5968 | 187/18723 | 1.04e-10 | 3.58e-09 | 102 |
GO:2001252111 | Thyroid | PTC | positive regulation of chromosome organization | 48/5968 | 82/18723 | 5.65e-07 | 9.04e-06 | 48 |
GO:00062606 | Thyroid | PTC | DNA replication | 114/5968 | 260/18723 | 3.09e-05 | 2.95e-04 | 114 |
GO:007058410 | Thyroid | PTC | mitochondrion morphogenesis | 13/5968 | 21/18723 | 4.41e-03 | 2.08e-02 | 13 |
GO:00323928 | Thyroid | PTC | DNA geometric change | 41/5968 | 90/18723 | 4.47e-03 | 2.11e-02 | 41 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa030304 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa034304 | Esophagus | ESCC | Mismatch repair | 21/4205 | 23/8465 | 2.85e-05 | 1.35e-04 | 6.90e-05 | 21 |
hsa0303011 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa0343011 | Esophagus | ESCC | Mismatch repair | 21/4205 | 23/8465 | 2.85e-05 | 1.35e-04 | 6.90e-05 | 21 |
hsa03030 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa03430 | Oral cavity | OSCC | Mismatch repair | 19/3704 | 23/8465 | 1.55e-04 | 5.34e-04 | 2.72e-04 | 19 |
hsa030301 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa034301 | Oral cavity | OSCC | Mismatch repair | 19/3704 | 23/8465 | 1.55e-04 | 5.34e-04 | 2.72e-04 | 19 |
hsa030302 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa034302 | Oral cavity | LP | Mismatch repair | 12/2418 | 23/8465 | 1.43e-02 | 4.59e-02 | 2.96e-02 | 12 |
hsa030303 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa034303 | Oral cavity | LP | Mismatch repair | 12/2418 | 23/8465 | 1.43e-02 | 4.59e-02 | 2.96e-02 | 12 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SSBP1 | SNV | Missense_Mutation | novel | c.311N>G | p.Lys104Arg | p.K104R | Q04837 | protein_coding | deleterious(0.03) | possibly_damaging(0.872) | TCGA-3C-AAAU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | zoladex | SD |
SSBP1 | SNV | Missense_Mutation | c.320G>A | p.Arg107Gln | p.R107Q | Q04837 | protein_coding | tolerated(0.06) | benign(0.282) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SSBP1 | SNV | Missense_Mutation | rs774947843 | c.94C>T | p.Arg32Cys | p.R32C | Q04837 | protein_coding | deleterious(0.03) | probably_damaging(0.969) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SSBP1 | SNV | Missense_Mutation | c.250T>C | p.Trp84Arg | p.W84R | Q04837 | protein_coding | tolerated(0.11) | probably_damaging(1) | TCGA-AA-3710-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SSBP1 | SNV | Missense_Mutation | c.128N>A | p.Pro43His | p.P43H | Q04837 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AY-6197-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SSBP1 | SNV | Missense_Mutation | c.314N>T | p.Gly105Val | p.G105V | Q04837 | protein_coding | deleterious(0) | probably_damaging(0.963) | TCGA-AZ-4313-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SSBP1 | SNV | Missense_Mutation | rs760601343 | c.271C>T | p.Arg91Trp | p.R91W | Q04837 | protein_coding | tolerated(0.07) | possibly_damaging(0.907) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SSBP1 | SNV | Missense_Mutation | c.320N>A | p.Arg107Gln | p.R107Q | Q04837 | protein_coding | tolerated(0.06) | benign(0.282) | TCGA-A5-A0GP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SSBP1 | SNV | Missense_Mutation | novel | c.86C>T | p.Ser29Phe | p.S29F | Q04837 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SSBP1 | SNV | Missense_Mutation | rs767820643 | c.31C>T | p.Arg11Cys | p.R11C | Q04837 | protein_coding | deleterious(0.04) | benign(0.003) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |